Jump Financial’s SQZ Biotechnologies Company SQZ Stock Holding History

Jump Financial’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-26,955	Closed	-$389K	–	1619
2021 Q2	$389K	Buy	+26,955	New	+$352K	0.04%	564

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jump Financial's SQZ Position: Q3 2021 in Review

Jump Financial sold out of SQZ Biotechnologies Company (SQZ) in Q3 2021, closing a stake of 26,955 shares — an estimated $389K sold.

Jump Financial first reported a position in SQZ in Q2 2021 and held it in 1 quarter. The position peaked at $389K in Q2 2021. 44 funds tracked by Wall St. Rank hold SQZ as of Q3 2021.

Jump Financial reported no remaining SQZ Biotechnologies Company position as of Q3 2021 after selling out during the quarter.
Jump Financial sold 26,955 SQZ Biotechnologies Company shares in Q3 2021, an estimated $389K.
Jump Financial first reported a position in SQZ Biotechnologies Company in Q2 2021 and held it in 1 quarter.
Jump Financial's SQZ Biotechnologies Company position peaked at $389K in Q2 2021.
44 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2021.

Based on Jump Financial's 13F filing for Q3 2021, filed 12 Nov 2021.